Feedback / Questions
milciclib (TZLS-201) - Tiziana Life Sci
Milciclib: Initiation of P2b trial for HCC in Q2 2021
(Tiziana Life Sciences)
-
Sep 23, 2020 -
Corporate Presentation
New P2 trial
•
Gastrointestinal Cancer • Hepatocellular Cancer • Oncology
https://ir.tizianalifesciences.com/static-files/a9b16682-0534-496e-a924-e9839de540e9
Sep 23, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious